Search results
Found 6776 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19
Coronavirus COVID-19 General Research
30 April 2021
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
New method for cost-effective genome-wide DNA methylation analysis
General Research
28 April 2021
Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
Azithromycin not effective against COVID-19, trial confirms
Clinical Trials General Research
28 April 2021
A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.
New malaria vaccine proves highly effective – and COVID shows how quickly it could be deployed
General Research
28 April 2021
Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine
Coronavirus COVID-19 General Research
23 April 2021
COVID-19 infections fell significantly – by 65% - after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study.
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Clinical Trials General Research
23 April 2021
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.
National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines
Coronavirus COVID-19 Research
23 April 2021
Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), is the first to show the impact of vaccination on antibody responses and new infections in a large group of adults from the general population aged 16 years and older.
Research uncovers high risk to pregnant women from COVID-19
Coronavirus COVID-19 Research
23 April 2021
A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.
General anaesthesia should be available for dying patients - medical and ethical experts
General Research
21 April 2021
General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).
Human challenge trial launches to study immune response to COVID-19
Clinical Trials Coronavirus COVID-19 General
19 April 2021
Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.
Risk of rare blood clotting higher for COVID-19 than for vaccines
Coronavirus COVID-19 Research
15 April 2021
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
Alternating vaccines trial expands to include two additional vaccines
Clinical Trials Coronavirus COVID-19 General
14 April 2021
Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.
Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment
General
13 April 2021
Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
Clinical Trials Coronavirus COVID-19 Research
12 April 2021
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.
UK and EU regulators conclude benefits of vaccination continue to outweigh the risks
Coronavirus COVID-19 General
7 April 2021
Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.